- Home
- CIO vs ABEO Comparison
CIO vs ABEO Comparison
Compare CIO & ABEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CIO
- ABEO
- Stock Information
- Founded
- CIO 2013
- ABEO 1974
- Country
- CIO Canada
- ABEO United States
- Employees
- CIO N/A
- ABEO N/A
- Industry
- CIO Real Estate Investment Trusts
- ABEO Biotechnology: Pharmaceutical Preparations
- Sector
- CIO Real Estate
- ABEO Health Care
- Exchange
- CIO Nasdaq
- ABEO Nasdaq
- Market Cap
- CIO 280.5M
- ABEO 289.2M
- IPO Year
- CIO 2014
- ABEO 1980
- Fundamental
- Price
- CIO $7.01
- ABEO $5.41
- Analyst Decision
- CIO Hold
- ABEO Strong Buy
- Analyst Count
- CIO 1
- ABEO 6
- Target Price
- CIO N/A
- ABEO $18.17
- AVG Volume (30 Days)
- CIO 548.8K
- ABEO 1.1M
- Earning Date
- CIO 10-30-2025
- ABEO 11-13-2025
- Dividend Yield
- CIO 5.72%
- ABEO N/A
- EPS Growth
- CIO N/A
- ABEO N/A
- EPS
- CIO N/A
- ABEO 0.99
- Revenue
- CIO $168,892,000.00
- ABEO $400,000.00
- Revenue This Year
- CIO $0.60
- ABEO N/A
- Revenue Next Year
- CIO $3.53
- ABEO $324.71
- P/E Ratio
- CIO N/A
- ABEO $5.47
- Revenue Growth
- CIO N/A
- ABEO N/A
- 52 Week Low
- CIO $4.19
- ABEO $3.93
- 52 Week High
- CIO $7.01
- ABEO $7.54
- Technical
- Relative Strength Index (RSI)
- CIO 74.58
- ABEO 35.22
- Support Level
- CIO $6.93
- ABEO $5.18
- Resistance Level
- CIO $6.97
- ABEO $5.65
- Average True Range (ATR)
- CIO 0.02
- ABEO 0.21
- MACD
- CIO -0.01
- ABEO -0.01
- Stochastic Oscillator
- CIO 93.75
- ABEO 35.94
About CIO City Office REIT Inc.
City Office REIT Inc is a real estate investment trust. It is focused on acquiring, owning, and operating high-quality office properties located predominantly in Sun Belt markets. The principal objective of the company is to provide attractive risk-adjusted returns to its investors over the long-term through a combination of dividends and capital appreciation. Its properties includes: Pima Center, SanTan, Park Tower, Intellicenter, Intellicenter, Denver Tech, Canyon Park, AmberGlen and many. The company own these office buildings in the metropolitan areas of Dallas, Denver, Orlando, Phoenix, Portland, Raleigh, San Diego, Seattle, and Tampa.
About ABEO Abeona Therapeutics Inc.
Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel.